An official website of the United States government
Home
Name
Sorafenib
Alternate Names
BAY 43-9006
BAY 439006
BAY439006
Nexavar
Abbreviations
None
Category
Chemotherapy
Subcategory
Targeted therapy--raf kinase inhibitor
NSC Number
None
Primary Site
Histology
None
Remarks
FDA approval 2005 for renal cell carcinoma (RCC)
FDA approval 2007 for hepatocellular carcinoma
FDA approval 2013 for thyroid carcinoma
Maybe used to treat other neoplasms and primary sites.
FDA approval 2007 for hepatocellular carcinoma
FDA approval 2013 for thyroid carcinoma
Maybe used to treat other neoplasms and primary sites.
Coding
This drug should be coded
